Personalized Cancer Vaccine Summit
Evvnt Promotion / evvnt
Archive
03.12.2024 - 05.12.2024 Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 8:00 AM - 5:00 PM
Conference themes
With recent advancements into Phase II and III trials for personalized cancer vaccines along with 437 other candidates in development, the biopharma industry is at a critical point to demonstrate safe and efficacious results that will offer a real hope for every patient with a cure for cancer.
With recent advancements into Phase II and III trials for personalized cancer vaccines along with 437 other candidates in development, the biopharma industry is at a critical point to demonstrate safe and efficacious results that will offer a real hope for every patient with a cure for cancer.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Notes
URL:
Brochure: https://go.evvnt.com/2558274-3?pid=4832
Speakers: Agnete Fredriksen, Chief Scientific Officer, Nykode Therapeutics, Charles Link, Chief Medical Officer, Syncromune, David Berd, Chief Medical Officer, Biovaxys, and more
URL:
Brochure: https://go.evvnt.com/2558274-3?pid=4832
Speakers: Agnete Fredriksen, Chief Scientific Officer, Nykode Therapeutics, Charles Link, Chief Medical Officer, Syncromune, David Berd, Chief Medical Officer, Biovaxys, and more
Enquiries and Registration:
https://go.evvnt.com/2558274-2?pid=4832
Ms. Isabel Weir
Oncology
Languages
English
English
Congress fees
USD 2599.00 - USD 5097.00
USD 2599.00 - USD 5097.00
Participants expected
1000 - 1000
1000 - 1000
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
